当前位置:首页 - 行情中心 - 翰宇药业(300199) - 财务分析 - 利润表

翰宇药业

(300199)

  

流通市值:81.06亿  总市值:107.49亿
流通股本:6.66亿   总股本:8.83亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入401,555,248.48325,278,801.43176,222,802.86704,321,731.88
营业收入401,555,248.48325,278,801.43176,222,802.86704,321,731.88
二、营业总成本635,023,336.89428,738,428.05201,091,127.75924,670,091.34
营业成本146,684,554.8893,418,150.249,589,539.9159,627,391.12
税金及附加7,849,806.556,494,405.322,138,543.2516,599,719.41
销售费用164,916,269.68111,207,682.8540,763,914.17375,805,964.14
管理费用105,750,385.2971,973,449.4135,413,183.95106,456,131.74
研发费用118,110,953.6387,802,058.2344,393,211.43158,676,672.37
财务费用91,711,366.8657,842,682.0428,792,735.05107,504,212.56
其中:利息费用87,730,992.3855,524,371.2927,907,368.98103,249,407.84
其中:利息收入172,725.28109,498.3659,437.78568,669.6
加:公允价值变动收益54,026,991.462,695,801.827,781,417.4-69,501,743.59
加:投资收益-12,928,783.98-12,257,669.44-263,908.12-20,265,791.59
资产处置收益106,293.4963,000.463,000.43,405,096.06
资产减值损失(新)12,114,959.96,855,843.76--50,432,739.19
信用减值损失(新)-11,679,875.27-8,330,894.56-1,766,646-39,492,096.42
其他收益28,746,770.923,757,181.719,243,596.0925,831,756.51
营业利润平衡项目0000
四、营业利润-163,081,731.97-30,676,362.9620,189,134.88-370,803,877.68
加:营业外收入131,158.468,552.9338,370.313,233,460.81
减:营业外支出13,905,715.641,591,439.933,305,199.495,242,157.07
利润总额平衡项目0000
五、利润总额-176,856,289.21-32,199,249.9616,922,305.7-372,812,573.94
减:所得税费用4,918,689.752,758,766.15-1,343,030.77-265,025.29
六、净利润-181,774,978.96-34,958,016.1118,265,336.47-372,547,548.65
持续经营净利润-181,774,978.96-34,958,016.1118,265,336.47-372,547,548.65
归属于母公司股东的净利润-180,549,363.99-34,133,703.8818,605,574.69-370,550,318.41
少数股东损益-1,225,614.97-824,312.23-340,238.22-1,997,230.24
(一)基本每股收益-0.2-0.040.02-0.42
(二)稀释每股收益-0.2-0.040.02-0.42
八、其他综合收益3,177,814.193,747,769.27-1,230,539.098,224,412.55
归属于母公司股东的其他综合收益3,177,814.193,747,769.27-1,230,539.098,224,412.55
九、综合收益总额-178,597,164.77-31,210,246.8417,034,797.38-364,323,136.1
归属于母公司股东的综合收益总额-177,371,549.8-30,385,934.6117,375,035.6-362,325,905.86
归属于少数股东的综合收益总额-1,225,614.97-824,312.23-340,238.22-1,997,230.24
公告日期2023-10-302023-08-152023-04-272023-04-27
审计意见(境内)标准无保留意见
TOP↑